Bioequivalence Study of a Fixed-dose Combination (FDC) of Dolutegravir (DTG) and Rilpivirine (RPV)
Clinical trial NCT02741557 · COMPLETED
Trial details
- NCT number
- NCT02741557
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-11
- Primary completion
- 2016-10-24
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.